Voyageur Pharmaceuticals Ltd. filed its Annual on Mar 30, 2023 for the period ending Nov 30, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | -16.67% | -28.57% | -33.33% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.33% | 6.14M | |
+57.48% | 823B | |
-7.18% | 353B | |
+15.37% | 320B | |
+7.45% | 295B | |
+13.62% | 239B | |
+14.55% | 220B | |
-0.33% | 219B | |
+8.14% | 167B | |
-2.99% | 159B |
- Stock Market
- Equities
- VM Stock
- News Voyageur Pharmaceuticals Ltd.
- Voyageur Pharmaceuticals Ltd. Auditor Raises 'Going Concern' Doubt